CD19
protein-codingCD19 molecule, the group of CD molecules|Minor histocompatibility antigens|Immunoglobulin like domain containing
Gene summary
This gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013283
Submitter: ClinGen
*CD19* was first reported in relation to autosomal recessive immunodeficiency, common variable, 3 in 2006 (van Zelm MC, et al., 2006, PMID: 16672701). On mature B cells, CD19, CD81, CD21 and CD225 form the CD19 complex that signals in conjunction with the B cell antigen receptor (BcR), thereby decreasing the threshold for BcR-dependent signaling. Biallelic variation in this gene thus results in profound hypogammaglobulinemia due to a poor response to antigen. These patients are characterized by moderately severe hypogammaglobulinemia, impaired antibody responses on vaccination, and impaired memory B-cell formation. This gene-disease relationship is supported by both genetic and experimental evidence. At least eight variants (missense, splice site, and frameshift) have been reported in seven probands (PMIDs: 16672701, 21159371, 24684239, 34490048 and 21330302) and three additional affected family members. A role in disease is supported by the function of *CD19* in lowering the threshold for antigen receptor stimulation (PMID: 1373518), which is disrupted in patient cells (PMID: 16672701). Expression of *CD19* during B-cell differentiation provides further evidence; the surface molecule CD19 appears early and remains on the B cell until it differentiates into a plasma cell (PMID: 6408173). A CD19-/- mouse model recapitulates the profound deficiency in responding to protein antigens as well as impaired response to vaccination (PMID: 7543183) and live virus (PMID: 9653091). Recapitulation of hypogammaglobulinemia in the CD19-/- mouse can be rescued by human CD19 (PMID: 9144478). In summary *CD19* is definitively associated with autosomal recessive immunodeficiency, common variable, 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0013283
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Indidivuals may demonstrate increased susceptibility to infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CD19 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001770.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 117 | 1 | 121 | ||
| missense | 1 | 1 | 167 | 11 | 180 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 5 | 1 | 2 | 8 | ||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 1 | 7 | ||
| Total | 8 | 9 | 172 | 129 | 1 | 319 |
Highest pathogenic variant AF is 0.0000030979088
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001761.3 | 14 | MANE Select | |
| Ensembl | ENSP00000437940.2 | 14 | MANE Select | |
| RefSeq | NP_001171569.1 | 14 | Standard | |
| RefSeq | NP_001372661.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Primary immunodeficiency - Homo sapiens (human)
- B cell receptor signaling pathway - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
- Epstein-Barr virus infection - Homo sapiens (human)
Biological Process
- cellular defense response
- cell surface receptor signaling pathway
- regulation of complement activation
- phosphatidylinositol phosphorylation
- regulation of immune response
Molecular Function
- protein binding
- phosphatidylinositol-4,5-bisphosphate 3-kinase activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- external side of plasma membrane
- protein-containing complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000538922
- Coding exons
- 14
- Length
- 7408
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125748
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.03 | 270 | 322 | 0.839 | 0.0000191 | 3571 |
| Missense (PolyPhen) | 124 | 150.04 | 0.82645 | 1639 | ||
| Synonymous | -0.217 | 138 | 135 | 1.02 | 0.00000856 | 1137 |
| Loss of Function | 4.19 | 5 | 29.6 | 0.169 | 0.00000134 | 343 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.;
- Disease
- DISEASE: Immunodeficiency, common variable, 3 (CVID3) [MIM:613493]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:16672701}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.517
Intolerance Scores
- LoFtool
- 0.411
- RVIS EVS
- -0.18
- RVIS percentile EVS
- 40.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.674
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |